The main purpose of this study is to evaluate the efficacy and safety of LY3871801 in adult participants with active moderately-to-severe rheumatoid arthritis (RA).
Age: 18 years - 66+
Gender: All
We've found 1 total result for "Arthritis Rheumatoid".